VENTANA PD-L1 (SP142) Assay Testing Sites

VENTANA PD-L1(SP142) Assay

The VENTANA PD-L1 (SP142) Assay:

  • FDA approved to assess NSCLC patient treatment benefit from TECENTRIQ® (atezolizumab)
  • Informative for the clinician of a patient’s potential overall survival
  • Novel scoring algorithm using PD-L1 staining in both TC and IC
  • Designed to enhance visual contrast of immune cell staining within the tumor microenvironment

The PD-L1 (SP142) Assay gives you the confidence to guide immunotherapy decisions in NSCLC.

*All randomized patients in a NSCLC phase III study observed benefit from TECENTRIQ (atezolizumab) regardless of PD-L1 status

Test Centers

Aurora Diagnostics LMC Pathology Services

7455 W. Washington Avenue, Suite 301
Las Vegas, NV 89128
Phone: 877-LMC-LABS
Phone: 702-732-3441
Fax: 702-732-2310
www.auroradxlmc.com

Integrated Oncology

www.integratedoncology.com
Arizona
Phone: 800-710-1800
Fax: 800-481-4151
New York
Phone: 800-447-5861
Fax: 212-258-2143
Tennesee
Phone: 800-874-8532
Fax: 615-370-8074

Laboratory Corporation of America

www.labcorp.com
Phone: 800-345-GENE (4363)
Fax: 888-287-8199
1904 Alexander Drive
Research Triangle Park, NC 27709

Mayo Clinic Laboratories

3050 Superior Drive NW
Rochester, MN 55901
1-800-533-1710
www.mayocliniclabs.com

NeoGenomics Laboratories

31 Columbia
Aliso Viejo, CA 92656
Phone: 888-443-3311
www.neogenomics.com

PhenoPath Laboratories

551 North 34th St, Suite 100
Seattle WA 98103
Phone: 206-374-9000
Fax: 206-374-9009
www.phenopath.com/

Providence Regional Laboratory Services

Test Code: PD-L1
4400 NE Halsey St
Portland, OR 97213
Phone: 503-893-7777
www.providence.org

Quest Diagnostics Nichols Institute

33608 Ortega Highway
San Juan Capistrano, CA 92690 USA
Phone: 949-728-4879
Fax: 949-728-4992
www.nicholsinstitute.com

Thomas Jefferson University Hospitals, Inc.

Test Code: PDL1 UC
132 S. 10th Street, Room 283 Main Bldg.
Philadelphia, PA 19107
Phone: 215-955-6352
www.jefferson.edu

If you would like your lab featured on this list, please opt in here.